Our news team
For all media queries, filming or interview requests
Keeping you up to date with all the Lymphoma Team news
In June the clinical trial co-ordinators held a cake sale to raise money for the Alzheimer’s Society.
They raised £65.00 which with gift aid will come to £81.25!
As it was such a success we have decided to hold a charity cake sale every couple of months for different charities of choice.
Well done to everyone who baked the extremely tasty cakes and thank you to each member of staff who donated money for a brilliant cause!
Professor Tim Illidge, Professor of Targeted Therapy and Oncology and three senior researchers based at The Christie have won prestigious honours from the Royal College of Radiologists (RCR).
Professor Illidge, received the RCR Gold Medal, the highest honour the college can award and made in recognition of his ‘enormous national and international contribution to clinical oncology’.
Prof Illidge is the first Manchester-based recipient of the award since Professor Ralston Paterson in 1966. Prof Paterson was a world-leading authority on treating cancer with radiotherapy and gave his name to the building on Wilmslow Road in Withington which was badly damaged by fire in April 2017.
Prof Illidge, who lives in Disley, is head of the division of cancer services at The University of Manchester and oversees a large number of academic staff. He said: “The medal came as a tremendous surprise but of course I’m really honoured and humbled to receive it.
“Awards such as this are always the result of a big team effort so it’s recognition of all the hard work my colleagues at The University of Manchester and The Christie have put in. I am thrilled that three of us from Manchester were honoured at the awards ceremony which shows that we are recognised as being at the forefront of clinical oncology in the UK.
“There have been very few oncologists to have won the gold medal in the last 50 years and it is great that Manchester has got this recognition again.”
The awards took place at the RCR’s annual Admission of Fellows ceremony at Westminster Central Hall in London.
The lymphoma team congratulate Tim and his colleagues for this fantastic achievement!
As part of the Christie celebrating the 70th anniversary of the NHS, for 70 days 70 individuals have been nominated by staff or patients as a 'Christie hero'.
We are pleased to announce that our very own Jane Gibson-Advanced Nurse Practitioner was nominated by Nigel Billings, a patient at The Christie. Nigel said “Jane was my Lymphoma Nurse and my first point of contact. Her support has helped me through this chapter of my life. She is a very special person to me.”
Within the last 12 months Jane has transitioned from a Clinical Nurse Specialist to an Advanced Nurse Practitioner and is excelling in her new role within the team.
Well done Jane, very well deserved!
In March the lymphoma team were the first in the UK to recruit two new patients with follicular lymphoma into the clinical trial ReBel. This new trial is to see how well lenalidomide and rituximab work with or without bendamustine in people with relapsed follicular lymphoma. For further information about this trial please click here.
Clinical trial patient Nigel and his wife Julie presented Dr Kim Linton with a beautiful hand crafted advent calendar for The Lymphoma Team just in time for advent!
We are delighted with the thoughtful gift which Julie has been making since August and it will have pride of place in our office for everyone to enjoy. Thank you to Nigel and Julie and a Merry Christmas to all our patients and their families!
In November Professor Radford was announced as winner of the ‘Lifetime Achievement’ category at the Greater Manchester Clinical Research Awards. He has led many practice-changing trials in lymphoma and is an internationally recognised leader in the field so as a team we are extremely pleased he was recognised in this way.
Professor Radford was humbled and regarded the award as ‘flying the flag for all the high impact clinical research going on at the Christie and our partners, including other trusts, The University of Manchester and Cancer Research UK'.
In July we became the first site in the world to open the new CTCL chart review study. This study looks at real-world treatment patterns and outcomes in relapsed/refractory cutaneous T-cell lymphoma (CTCL).
We give a warm welcome to our new research nurse Chiara Dallatorre who started on the team in June 2017. Chiara is an experienced haematology nurse who has previously worked for Blackpool Victoria Hospital and we are sure she will make a great addition to our research team.
Professor John Radford has recently been invited to join the editorial board of the AOL (Annals of Lymphoma) which is a rising high quality electronic journal, openly distributed worldwide relating to lymphoma research.
In January Professor Radford and Dr Gibb were named as lead authors on a Pfizer abstract to be presented at the International Conference on Malignant Lymphoma in Lugano, Switzerland in June 2017.